Clinical Trials Directory

Trials / Sponsors / Nerviano Medical Sciences

Nerviano Medical Sciences

Industry · 15 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
Ovarian Cancer
Phase 12026-04-30
RecruitingStudy of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 12025-08-15
RecruitingStudy of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Relapsed/Refractory Acute Myeloid Leukemia
Phase 12024-10-16
TerminatedPh I Study in Adult Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12022-09-09
Active Not RecruitingPh I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
Glioblastoma, Diffuse Glioma
Phase 1 / Phase 22021-12-01
TerminatedStudy on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HC
Unresectable Hepatocellular Carcinoma (HCC)
Phase 1 / Phase 22020-11-13
TerminatedStudy of NMS-03305293 in Pts with Selected Advanced/Metastatic Solid Tumors
Advanced/Metastatic Solid Tumors
Phase 12019-11-25
TerminatedStudy of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML
Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML)
Phase 1 / Phase 22019-04-03
TerminatedStudy of NMS-1116354 in Advanced/Metastatic Solid Tumors
Advanced/Metastatic Solid Tumors
Phase 12010-01-01
CompletedStudy of NMS-1286937 in Adult Patients With Advanced/Metastatic Solid Tumors
Advanced or Metastatic Solid Tumors
Phase 12009-11-01
TerminatedStudy of NMS-1116354 in Solid Tumors
Advanced Solid Tumors
Phase 12009-04-01
TerminatedPHA-739358 for the Treatment of Multiple Myeloma
Multiple Myeloma
Phase 22008-10-01
CompletedPHA-739358 for Treatment of Hormone Refractory Prostate Cancer
Metastatic Hormone Refractory Prostate Cancer
Phase 22007-09-01
TerminatedDose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors
Advanced/Metastatic Solid Tumors
Phase 12006-11-01
CompletedStudy of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors
Solid Tumour
Phase 12006-04-01